Study shows UK recall rise

Manufacturing missteps are behind the near quadrupling of drug and medical device recalls in the UK between 2004 and 2008. A study by marketing concern Blueview Group shows that recalls and product alerts climbed to 94 from just 22, with nearly two-thirds attributed to manufacturing defects.

The study finds that 12 percent of pharma recalls stem from labeling and packaging problems, according to an online report, while nine percent are due to compromised sterility.

Another finding: food product recalls have remained more stable during the rapid rise of pharma and non-food consumer product recalls and safety alerts.

- here's the report

Suggested Articles

Eli Lilly is investing $400 million in itsĀ Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.